Patents by Inventor Soren Moller

Soren Moller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOY BUILDING BRICKS MADE OF RECYCLED ABS MATERIAL
    Publication number: 20230193018
    Abstract: A toy building element made of recycled Acrylonitrile Butadiene Styrene (“ABS”) material and manufactured by processing, of a resin comprising, mechanically recycled ABS polymers and/or chemically recycled ABS polymers recovered from a solvent dissolution recycling process. A method for the manufacture of a toy building element includes providing and screening an ABS waste material. The method includes recovering recycled ABS polymers from the screened ABS waste material by subjecting the ABS waste material to grinding and/or a solvent dissolution recycling process. The method includes obtaining a resin by mixing the recovered ABS polymers with one or more additive(s) and optionally one or more ABS polymers selected from the group consisting of virgin ABS polymers, chemically recycled ABS polymers recovered from pyrolysis and chemically recycled ABS polymers recovered from chemical depolymerisation. The method thereafter includes manufacturing the toy building element by processing the resin.
    Type: Application
    Filed: October 14, 2022
    Publication date: June 22, 2023
    Inventors: Søren KRISTIANSEN, Søren MØLLER-SØRENSEN, René MIKKELSEN, Bistra ANDERSEN, Emil ANDERSEN, Carina Gejl NIELSEN, Anders Christian JENSEN
  • In situ hybridization method and buffer
    Patent number: 10023912
    Abstract: An improved method of in situ hybridization which relies on an improved formulation of the in situ hybridization buffer is described. In at least some formulations the buffer are non-toxic. The combination of Locked Nucleic Acid (LNA) comprising ISH probes and the improved ISH buffer are useful for detection of small non-coding RNA as well as in the manufacturing of ISH kits directed to the detection of such small non-coding RNA. Further disclosed is a method of semi-quantitative ISH and demonstration of the semi-quantitative ISHs diagnostic potential.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: July 17, 2018
    Assignee: EXIQON A/S
    Inventors: Boye Schnack Nielsen, Stine Jørgensen, Jan Skouv, Adam Baker, Søren Møller
  • In Situ Hybridization Method And Buffer
    Publication number: 20160160278
    Abstract: An improved method of in situ hybridization which relies on an improved formulation of the in situ hybridization buffer is described. In at least some formulations the buffer are non-toxic. The combination of Locked Nucleic Acid (LNA) comprising ISH probes and the improved ISH buffer are useful for detection of small non-coding RNA as well as in the manufacturing of ISH kits directed to the detection of such small non-coding RNA. Further disclosed is a method of semi-quantitative ISH and demonstration of the semi-quantitative ISHs diagnostic potential.
    Type: Application
    Filed: December 4, 2015
    Publication date: June 9, 2016
    Inventors: Boye Schnack NIELSEN, Stine JØRGENSEN, Jan SKOUV, Adam BAKER, Søren MØLLER
  • In situ hybridization method and buffer
    Patent number: 9212390
    Abstract: An improved method of in situ hybridization which relies on an improved formulation of the in situ hybridization buffer is described. In at least some formulations the buffer are non-toxic. The combination of Locked Nucleic Acid (LNA) comprising ISH probes and the improved ISH buffer are useful for detection of small non-coding RNA as well as in the manufacturing of ISH kits directed to the detection of such small non-coding RNA. Further disclosed is a method of semi-quantitative ISH and demonstration of the semi-quantitative ISHs diagnostic potential.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: December 15, 2015
    Assignee: EXIQON A/S
    Inventors: Boye Schnack Nielsen, Stine Jørgensen, Jan Skouv, Adam Baker, Søren Møller
  • Azaisoquinolinone derivatives as NK3 antagonists
    Publication number: 20130190499
    Abstract: The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Application
    Filed: March 11, 2011
    Publication date: July 25, 2013
    Applicant: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Klaus Bæk Simonsen, Søren Møller Nielsen, Karsten Juhl
  • In Situ Hybridization Method And Buffer
    Publication number: 20130164750
    Abstract: An improved method of in situ hybridization which relies on an improved formulation of the in situ hybridization buffer is described. In at least some formulations the buffer are non-toxic. The combination of Locked Nucleic Acid (LNA) comprising ISH probes and the improved ISH buffer are useful for detection of small non-coding RNA as well as in the manufacturing of ISH kits directed to the detection of such small non-coding RNA. Further disclosed is a method of semi-quantitative ISH and demonstration of the semi-quantitative ISHs diagnostic potential.
    Type: Application
    Filed: April 28, 2011
    Publication date: June 27, 2013
    Applicant: EXIQON A/S
    Inventors: Boye Schnack Nielsen, Stine Jørgensen, Jan Skouv, Adam Baker, Søren Møller
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8420667
    Abstract: Isoquinolone derivatives of the general formula Ik? are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: April 16, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8415373
    Abstract: Isoquinolone derivatives of the general formula (I) are NK3 antagonists.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: April 9, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8415356
    Abstract: Isoquinolone derivatives of the general formula I are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: April 9, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Søren Møller Nielsen, Klaus Bæk Simonsen
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8242134
    Abstract: The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: August 14, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • NOVEL HUMAN MICRORNAS ASSOCIATED WITH CANCER
    Publication number: 20120184603
    Abstract: The invention provides new sequences for human microRNAs associated with cancer which may be used as molecular markers for cancer diagnostics or as therapeutic targets or agents.
    Type: Application
    Filed: March 30, 2012
    Publication date: July 19, 2012
    Applicant: Exiqon A/S
    Inventors: Thomas Litman, Søren Møller, Søren Morgenthaler Echwald, Morten Lindow, Anders Martin Bøgild Jacobsen, Anders Stærmose Krogh, Sanne Nygaard, Rolf Søkilde
  • Window with a ventilation device
    Patent number: 8221201
    Abstract: A ventilation device for ventilation of a building having a double-window construction with an air space. The device communicates with the open air space and has four throttles. The first and the second throttles can selectively cut off the passage of air from the air space into a first and a second chamber, respectively, of the device. The third throttle can selectively cut off the passage of air from the first chamber and into the building. The fourth throttle can selectively cut off the passage of air between the open air space and the first and the second chamber. Temperature-sensitive actuators can activate the throttles, selectively adjusting air flow.
    Type: Grant
    Filed: October 19, 2005
    Date of Patent: July 17, 2012
    Inventors: Poul Christensen, Jens Arboe Harild, Soren Møller Madsen, Niels Herskind
  • Pyridone derivatives as NK3 antagonists
    Patent number: 8207347
    Abstract: The present invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: June 26, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Søren Møller Nielsen, Karsten Juhl, Lars Kyhn Rasmussen
  • Human microRNAs associated with cancer
    Patent number: 8188255
    Abstract: The invention provides new sequences for human microRNAs associated with cancer which may be used as molecular markers for cancer diagnostics or as therapeutic targets or agents.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: May 29, 2012
    Assignee: Exiqon A/S
    Inventors: Thomas Litman, Søren Møller, Søren Morgenthaler Echwald, Morten Lindow, Anders Martin Bøgild Jacobsen, Anders Stærmose Krogh, Sanne Nygaard, Rolf Søkilde
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8173639
    Abstract: Isoquinolone derivatives of the general formula are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: May 8, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Klaus Baek Simonsen, Jan Kehler, Karsten Juhl, Nikolay Khanzhin, Soren Moller Nielsen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110288120
    Abstract: Isoquinolone derivatives of the general formula (I) are NK3 antagonists.
    Type: Application
    Filed: October 16, 2009
    Publication date: November 24, 2011
    Applicant: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • AZAISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110224247
    Abstract: The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 15, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Klaus Bæk Simonsen, Søren Møller Nielsen, Karsten Juhl
  • Pyridone derivatives as NK3 antagonists
    Publication number: 20110144164
    Abstract: The present invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Application
    Filed: December 14, 2010
    Publication date: June 16, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Søren Møller Nielsen, Karsten Juhl, Lars Kyhn Rasmussen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110130420
    Abstract: Isoquinolone derivatives of the general formula Ik? are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Application
    Filed: April 22, 2009
    Publication date: June 2, 2011
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110130407
    Abstract: Isoquinolone derivatives of the general formula I are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Application
    Filed: June 19, 2009
    Publication date: June 2, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Søren Møller Nielsen, Klaus Baek Simonsen